Canadian firms to ensure safety of glucose strips
This article was originally published in Clinica
Executive Summary
Initiatives to protect the "integrity" of blood glucose strips against poor handling, shipment and documentation procedures, will be undertaken this year by members of Canada's association for medical device and technology companies (MEDEC). MEDEC's position is that "the safety and integrity of test strips is a joint responsibility of all parties in the supply chain", but research by companies has found that "further education among all parties in the supply chain - wholesalers, distributors, sales representatives, pharmacies and healthcare providers" is required to ensure that industry best practices are achieved.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.